Prospective validation of stringent dose constraints for prostatic stereotactic radiation monotherapy: results of a single-arm phase II toxicity-oriented trial-Reference-Cited by-同舟云学术

Prospective validation of stringent dose constraints for prostatic stereotactic radiation monotherapy: results of a single-arm phase II toxicity-oriented trial

Published:2021-08-23 Issue:11 Volume:197 Page:1001-1009
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Nguyen Paul^ORCID,Harzée Ludovic,Retif Paul,Joseph Stéphane,Vogin Guillaume,Nickers Philippe

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-021-01832-y.pdf

Reference33 articles.

1. Dearnaley D, Syndikus I, Mossop H et al (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer : 5‑year outcomes of the randomised , non-inferiority , phase 3 CHHiP trial. Lancet Oncol 17(8):1047–1060. https://doi.org/10.1016/S1470-2045(16)30102-4

2. Catton CN, Lukka H, Gu CS et al (2017) Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer. J Clin Oncol 35(17):1884–1890. https://doi.org/10.1200/JCO.2016.71.7397

3. Incrocci L, Wortel RC, Alemayehu WG et al (2016) Hypofractionated versus conventionally frationated radiotherapy for patients with localised prostate cancer ( HYPRO ): final efficacy results from a randomised , multicentre , open-label , phase 3 trial. Lancet Oncol 2045(16):1–9. https://doi.org/10.1016/S1470-2045(16)30070-5

4. Demanes DJ, Martinez AA, Ghilezan M et al (2011) High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 81(5):1286–1292. https://doi.org/10.1016/j.ijrobp.2010.10.015

5. Barkati M, Williams SG, Foroudi F et al (2012) High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial. Int J Radiat Oncol Biol Phys 82(5):1889–1896. https://doi.org/10.1016/j.ijrobp.2010.09.006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes in studies regarding older patients with prostate cancer: A systematic review;Journal of Geriatric Oncology;2024-06

2. Stereotactic focal radiotherapy as an alternative treatment for low-risk prostate cancer: Results of a single-arm monocenter Phase-II trial;Frontiers in Oncology;2023-04-06